BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2016
View Archived Issues
Otsuka tuberculosis candidate granted U.S. orphan drug designation
Read More
DynPort Vaccine Company plague vaccine granted FDA orphan drug status
Read More
Neutralizing human MAbs protect against infection and maternal-fetal transmission of ZIKV in vivo
Read More
Ortho-McNeil-Janssen Pharmaceuticals and KU Leuven patent dengue viral replication inhibitors
Read More
Roche and Genentech disclose ERalpha ligands
Read More
Cardiome Pharma launches Xydalba in U.K.
Read More
FDA accepts durvalumab BLA for urothelial cancer
Read More
GlaxoSmithKline describes KMO inhibitors
Read More
3D microtissue engineering used to generate hypertrophic cardiomyopathy cardiomyocytes
Read More
Soligenix reports long-term follow-up data from phase II trial of SGX-942 for oral mucositis
Read More
New U.K. alliance established to accelerate development of treatments for arthritis
Read More
SNPs in BDNF and GSK-3beta may be associated with bipolar disorder
Read More
AstraZeneca initiates phase I study of abediterol and AZD-7594
Read More
E2F4 activation shows promise for SCI recovery
Read More
Phase III trials show no benefit in adding Fovista to Lucentis for wet AMD
Read More
New MGL inhibitor shows promise for the treatment of pain
Read More
Valeant Pharmaceuticals reports positive results from phase III study of IDP-118
Read More
Synergy reports results from first phase III trial of plecanatide for IBS-C
Read More
BioInvent terminates phase II study of BI-505 in multiple myeloma
Read More
New phase I trial explores use of PGT-121 for HIV prevention and therapy
Read More
Seattle Genetics initiates phase I trial of SGN-CD352A in relapsed or refractory multiple myeloma
Read More